PBH
Prestige Consumer Healthcare Inc.
$63.10
-$1.00(-1.56%)
59
Overall
80
Value
36
Tech
63
Quality
Market Cap
$3.12B
Volume
1.03M
52W Range
$61.93 - $90.04
Target Price
$85.67
Order:
Income Statement
| Metric | Trend | Chart | 2016 Mar | 2017 Mar | 2018 Mar | 2019 Mar | 2020 Mar | 2021 Mar | 2022 Mar | 2023 Mar | 2024 Mar | 2025 Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $806.2M | $882.1M | $1.0B | $975.8M | $963.0M | $943.4M | $1.1B | $1.1B | $1.1B | $1.1B | ||
| Total Revenue | $803.1M | $881.1M | $1.0B | $975.8M | $963.0M | $943.4M | $1.1B | $1.1B | $1.1B | $1.1B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-339.0M | $-381.8M | $-464.7M | $420.2M | $410.8M | $395.9M | $466.2M | -- | -- | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $467.2M | $500.3M | $576.5M | $555.6M | $552.2M | $547.5M | $620.6M | $625.3M | $624.4M | $634.5M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-206.9M | $-294.6M | $-361.0M | $488.1M | $261.1M | $250.1M | $290.7M | $277.5M | $282.0M | $297.7M | ||
| Selling, General & Administrative | $183.2M | $217.5M | $232.7M | $232.8M | $236.3M | $226.1M | $272.0M | $252.4M | $259.5M | $263.9M | ||
| Selling & Marketing Expenses | $110.8M | $128.4M | $147.3M | $143.1M | $147.2M | $140.6M | $164.6M | $145.1M | $153.3M | $155.7M | ||
| General & Administrative Expenses | $72.4M | $89.1M | $85.4M | $89.8M | $89.1M | $85.5M | $107.5M | $107.4M | $106.2M | $108.2M | ||
| Promotion & Advertising | -- | -- | -- | -- | -- | -- | $7.2M | -- | -- | -- | ||
| Salaries & Wages | $-10.0M | $-8.1M | $-8.9M | $-1.4M | $-1.2M | $-1.2M | $-633.0K | -- | -- | $8.9M | ||
| Depreciation & Amortization | $23.7M | $25.8M | $33.4M | $27.0M | $24.8M | $30.2M | $24.9M | $25.1M | $22.6M | $21.3M | ||
| Depreciation & Amortization | $23.7M | $25.8M | $33.4M | $27.0M | $24.8M | $30.2M | $24.9M | $25.1M | $22.6M | $21.3M | ||
| Amortization | $23.7M | $25.8M | $28.4M | $27.0M | $24.8M | $30.2M | $24.9M | $25.1M | $22.6M | $21.3M | ||
| Securities Amortization | -- | -- | -- | -- | $4.2M | -- | -- | -- | -- | -- | ||
| Other Operating Expenses | $-206.9M | $-294.7M | $-361.0M | $-585.0K | $-495.0K | -- | $-2.9M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $260.3M | $257.4M | $315.4M | $67.5M | $291.2M | $297.4M | $329.9M | $-22.4M | $342.4M | $336.8M | ||
| EBITDA | $275.2M | $238.8M | $253.5M | $104.7M | $320.2M | $316.6M | $358.8M | $12.2M | $379.1M | $363.7M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $85.3M | $93.5M | $106.3M | $105.1M | $96.2M | $82.3M | $64.3M | $69.2M | $67.2M | $47.6M | ||
| Intinc | $162.0K | $203.0K | $388.0K | $217.0K | $342.0K | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-85.2M | $-93.3M | $-105.9M | $-104.9M | $-96.2M | $-82.3M | $-64.3M | $-69.2M | $-67.2M | $-47.6M | ||
| Gain on Sale of Securities | -- | $-51.8M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $18.0M | $53.2M | $2.5M | $476.0K | $3.8M | $11.0M | $3.2M | $-372.6M | $-756.0K | $5.0M | ||
| Other Special Charges | $-18.0M | $-1.4M | $-2.5M | $-476.0K | $-3.8M | $-11.0M | $-3.2M | $-2.3M | $756.0K | $-5.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | $-103.1M | -- | $-99.9M | $-458.9M | $750.0K | $-2.4M | $-1.1M | $-377.8M | $-8.1M | $-12.5M | ||
| Impairment of Capital Assets | -- | -- | $99.9M | $458.9M | -- | $2.4M | $1.1M | $370.2M | -- | $12.5M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $242.5M | $204.4M | $213.4M | $67.0M | $287.4M | $286.4M | $326.7M | $-24.8M | $343.2M | $331.8M | ||
| Pre-Tax Income | $157.2M | $110.8M | $107.1M | $-38.1M | $191.2M | $204.1M | $262.5M | $401.0M | $768.8M | $778.6M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $57.3M | $41.5M | $-232.5M | $-2.3M | $48.9M | $39.4M | $57.1M | $-11.6M | $66.7M | $69.6M | ||
| NET INCOME | ||||||||||||
| Net Income | $-3.2M | $69.4M | $339.6M | $-35.8M | $142.3M | $164.7M | $205.4M | $-82.3M | $209.3M | $214.6M | ||
| Net Income (Continuing Operations) | $-3.2M | $69.4M | $339.6M | $-35.8M | $142.3M | $164.7M | $205.4M | $-82.3M | $209.3M | $214.6M | ||
| Net Income (Discontinued Operations) | $-3.2M | $69.4M | $339.6M | $-35.8M | $142.3M | $164.7M | $205.4M | $-82.3M | $209.3M | $214.6M | ||
| Net Income (Common Stockholders) | $-3.2M | $69.4M | $339.6M | $150.4M | $548.8M | $164.7M | $205.4M | $-82.3M | $209.3M | $214.6M | ||
| Normalized Income | -- | -- | -- | -- | -- | $164.9M | $210.1M | -- | -- | $783.3M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-545.9M | $-676.4M | $-825.7M | $908.3M | $671.9M | $646.0M | $756.9M | $277.5M | $282.0M | $297.7M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $52.8M | $53.0M | $53.1M | $52.1M | $50.7M | $50.2M | $50.3M | $49.9M | $49.8M | $49.7M | ||
| Average Shares Outstanding (Diluted) | $53.1M | $53.4M | $53.5M | $52.1M | $51.1M | $50.6M | $50.8M | $49.9M | $50.2M | $50.1M | ||
| Shares Outstanding | $52.8M | $53.0M | $53.1M | $51.8M | $50.1M | $49.9M | $50.3M | $49.7M | $49.9M | $49.4M | ||
| Basic EPS | $1.89 | $1.31 | $6.4 | $-0.69 | $2.81 | $3.28 | $4.09 | $-1.65 | $4.21 | $4.32 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $-0.69 | $2.81 | $3.28 | $4.09 | $-1.65 | $4.21 | $4.32 | ||
| Diluted EPS | $1.88 | $1.3 | $6.34 | $-0.69 | $2.78 | $3.25 | $4.04 | $-1.65 | $4.17 | $4.29 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-0.69 | $2.78 | $3.25 | $4.04 | $-1.65 | $4.17 | $4.29 | ||
| OTHER METRICS | ||||||||||||
| Acquired In Process Rn D | $-103.1M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Excise Taxes | -- | -- | -- | $4.7M | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of Business | $-103.1M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | $35.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | -- | -- | -- | $1.3M | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | -- | -- | -- | -- | -- | -- | -- | $7.5M | -- | -- | ||
| Loss And Loss Adjustment Expected Incurred | -- | -- | -- | -- | -- | $6.2M | -- | -- | -- | -- | ||
| Marketing Expense | $110.8M | $128.4M | $147.3M | $143.1M | $147.2M | $140.6M | $157.3M | $145.1M | $153.3M | $155.7M | ||
| Net Income Discontinuous Operations | -- | -- | -- | $1.3M | -- | -- | -- | -- | -- | -- | ||
| Net Operating Interest Income Expense | $-23.1M | $-32.8M | $-26.8M | -- | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | -- | -- | -- | $7.5M | $8.1M | -- | ||
| Other Gand A | $72.4M | $89.1M | $85.4M | $89.8M | $89.1M | $85.5M | $107.5M | $107.4M | $106.2M | $108.2M | ||
| Other Impairment Of Capital Assets | -- | -- | $-99.9M | $195.9M | -- | $1.2M | $1.7M | -- | -- | -- | ||
| Other Write Off | -- | -- | -- | -- | $4.2M | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $72.4M | $89.1M | $85.4M | $2.4M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | -- | -- | -- | -- | -- | -- | $7.2M | -- | -- | -- | ||
| Write Down | -- | -- | -- | $-71.4M | $-750.0K | -- | -- | -- | -- | -- | ||
| Othspecchg | -- | -- | -- | -- | -- | -- | -- | -- | $8.1M | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PBH | $63.10 | -1.6% | 1.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Prestige Consumer Healthcare Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW